508 related articles for article (PubMed ID: 26903545)
21. Therapeutic effects of telomerase in mice with pulmonary fibrosis induced by damage to the lungs and short telomeres.
Povedano JM; Martinez P; Serrano R; Tejera Á; Gómez-López G; Bobadilla M; Flores JM; Bosch F; Blasco MA
Elife; 2018 Jan; 7():. PubMed ID: 29378675
[TBL] [Abstract][Full Text] [Related]
22. Genomic insult oriented mitochondrial instability and proliferative hindrance in the bone marrow of aplastic mice including stem/progenitor population.
Chatterjee R; Law S
Pathol Res Pract; 2019 Apr; 215(4):784-793. PubMed ID: 30683472
[TBL] [Abstract][Full Text] [Related]
23. Pathophysiologic mechanisms in acquired aplastic anemia.
Young NS
Hematology Am Soc Hematol Educ Program; 2006; ():72-7. PubMed ID: 17124043
[TBL] [Abstract][Full Text] [Related]
24. Telomerase mutations in aplastic anemia.
Fibbe WE
N Engl J Med; 2005 Apr; 352(14):1481-3. PubMed ID: 15814885
[No Abstract] [Full Text] [Related]
25. FANCC suppresses short telomere-initiated telomere sister chromatid exchange.
Rhee DB; Wang Y; Mizesko M; Zhou F; Haneline L; Liu Y
Hum Mol Genet; 2010 Mar; 19(5):879-87. PubMed ID: 20022886
[TBL] [Abstract][Full Text] [Related]
26. Mutations in the SBDS gene in acquired aplastic anemia.
Calado RT; Graf SA; Wilkerson KL; Kajigaya S; Ancliff PJ; Dror Y; Chanock SJ; Lansdorp PM; Young NS
Blood; 2007 Aug; 110(4):1141-6. PubMed ID: 17478638
[TBL] [Abstract][Full Text] [Related]
27. Bone marrow failure and the new telomere diseases: practice and research.
Young NS
Hematology; 2012 Apr; 17 Suppl 1():S18-21. PubMed ID: 22507770
[TBL] [Abstract][Full Text] [Related]
28. Aplastic anemia: Etiology, molecular pathogenesis, and emerging concepts.
Shallis RM; Ahmad R; Zeidan AM
Eur J Haematol; 2018 Dec; 101(6):711-720. PubMed ID: 30055055
[TBL] [Abstract][Full Text] [Related]
29. Structural Analysis Reveals the Deleterious Effects of Telomerase Mutations in Bone Marrow Failure Syndromes.
Hoffman H; Rice C; Skordalakes E
J Biol Chem; 2017 Mar; 292(11):4593-4601. PubMed ID: 28154186
[TBL] [Abstract][Full Text] [Related]
30. [Role of Telomere in Clonal Evolution of Acquired Aplastic Anemia--Review].
Li DN; Wen XH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Jun; 32(3):962-964. PubMed ID: 38926996
[TBL] [Abstract][Full Text] [Related]
31. Lentiviral gene transfer regenerates hematopoietic stem cells in a mouse model for Mpl-deficient aplastic anemia.
Heckl D; Wicke DC; Brugman MH; Meyer J; Schambach A; Büsche G; Ballmaier M; Baum C; Modlich U
Blood; 2011 Apr; 117(14):3737-47. PubMed ID: 21289307
[TBL] [Abstract][Full Text] [Related]
32. Telomere length dynamics in normal individuals and in patients with hematopoietic stem cell-associated disorders.
Brümmendorf TH; Rufer N; Holyoake TL; Maciejewski J; Barnett MJ; Eaves CJ; Eaves AC; Young N; Lansdorp PM
Ann N Y Acad Sci; 2001 Jun; 938():293-303; discussion 303-4. PubMed ID: 11458518
[TBL] [Abstract][Full Text] [Related]
33. Dietary restriction ameliorates haematopoietic ageing independent of telomerase, whilst lack of telomerase and short telomeres exacerbates the ageing phenotype.
Al-Ajmi N; Saretzki G; Miles C; Spyridopoulos I
Exp Gerontol; 2014 Oct; 58():113-9. PubMed ID: 25038516
[TBL] [Abstract][Full Text] [Related]
34. Telomerase redux: ready for prime time?
Larrick JW; Mendelsohn AR
Rejuvenation Res; 2015 Apr; 18(2):185-7. PubMed ID: 25790341
[TBL] [Abstract][Full Text] [Related]
35. Paroxysmal nocturnal hemoglobinuria and telomere length predicts response to immunosuppressive therapy in pediatric aplastic anemia.
Narita A; Muramatsu H; Sekiya Y; Okuno Y; Sakaguchi H; Nishio N; Yoshida N; Wang X; Xu Y; Kawashima N; Doisaki S; Hama A; Takahashi Y; Kudo K; Moritake H; Kobayashi M; Kobayashi R; Ito E; Yabe H; Ohga S; Ohara A; Kojima S;
Haematologica; 2015 Dec; 100(12):1546-52. PubMed ID: 26315930
[TBL] [Abstract][Full Text] [Related]
36. Mutations in XLF/NHEJ1/Cernunnos gene results in downregulation of telomerase genes expression and telomere shortening.
Carrillo J; Calvete O; Pintado-Berninches L; Manguan-García C; Sevilla Navarro J; Arias-Salgado EG; Sastre L; Guenechea G; López Granados E; de Villartay JP; Revy P; Benitez J; Perona R
Hum Mol Genet; 2017 May; 26(10):1900-1914. PubMed ID: 28369633
[TBL] [Abstract][Full Text] [Related]
37. Gene therapy with the TRF1 telomere gene rescues decreased TRF1 levels with aging and prolongs mouse health span.
Derevyanko A; Whittemore K; Schneider RP; Jiménez V; Bosch F; Blasco MA
Aging Cell; 2017 Dec; 16(6):1353-1368. PubMed ID: 28944611
[TBL] [Abstract][Full Text] [Related]
38. Telomerase RNA levels limit the telomere length equilibrium.
Greider CW
Cold Spring Harb Symp Quant Biol; 2006; 71():225-9. PubMed ID: 17381301
[TBL] [Abstract][Full Text] [Related]
39. Updates on the pathophysiology and treatment of aplastic anemia: a comprehensive review.
Boddu PC; Kadia TM
Expert Rev Hematol; 2017 May; 10(5):433-448. PubMed ID: 28452257
[TBL] [Abstract][Full Text] [Related]
40. Telomerase gene mutation screening in Chinese patients with aplastic anemia.
Han B; Liu B; Cui W; Wang X; Lin J; Zhao Y
Leuk Res; 2010 Feb; 34(2):258-60. PubMed ID: 19942288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]